Comprehensive Atrial Fibrillation Market Forecast 2025-2034: Growth Trends and Strategic Shifts

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Atrial Fibrillation Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The size of the atrial fibrillation market has seen swift expansion in recent times. It is projected to rise from $13.56 billion in 2024 to $15.14 billion in 2025, showing a compound annual growth rate (CAGR) of 11.7%. This growth from the previous period is due to factors such as increasing awareness and screening initiatives, advances in treatment technologies, higher healthcare spending, development in clinical research and drug discovery, and genetic susceptibility.

Atrial Fibrillation Market Size Forecast: What's the Projected Valuation by 2029?
The market for atrial fibrillation is anticipated to experience swift expansion in the coming years, reaching $24.93 billion by 2029, with a compound annual growth rate (CAGR) of 13.3%. The considerable growth expected in this period can be accredited to an emphasis on preventing strokes, the offering of education programs for both patients and physicians, worldwide initiatives promoting cardiovascular health, an increase in electrophysiology procedures, customization of treatment protocols and governmental efforts to hinder cardiovascular diseases. The key trends predicted for this period are progress in diagnostic technologies, a surge in atrial fibrillation instances, improvements in catheter ablation procedures, the emergence of novel oral anticoagulants (NOACs), the incorporation of wearable technology for supervision, the expanding application of telemedicine in managing AF, and forward strides in implantable devices.

View the full report here:
https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

What Are the Drivers Transforming the Atrial Fibrillation Market?
The progression of the atrial fibrillation market is anticipated to be fueled by the rise in the geriatric population. This category pertains to individuals aged 65 and over who have a higher propensity to suffer falls due to various reasons like postural hypotension and issues with balance or walking. Most older adults exhibit age-related factors and conduction disturbances on their surface electrocardiograms prior to the onset of AF. For example, the World Health Organization, a Switzerland-based United Nations specialized agency for international public health, projected in October 2022 that by 2030, six people in the world will be aged 60 years or older. The global population of those aged 60 years or older will increase to 1.4 billion, a significant jump from 1 billion in 2020. By 2050, the world's population of those aged 60 and older will double to 2.1 billion. Furthermore, between 2020 and 2050, the number of individuals aged 80 or over will increase by 426 million. Thus, the surge in the elderly population is propelling the expansion of the atrial fibrillation market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8007&type=smp

What Long-Term Trends Will Define the Future of the Atrial Fibrillation Market?
Principal players in the atrial fibrillation market are introducing cutting-edge products such as clinical decision support tools centered on patient needs, in order to consolidate their market standing. Clinical decision support tools (CDSTs) are digital systems or applications developed to help healthcare professionals make prompt and well-informed decisions regarding patient care. They are designed to amalgamate significant clinical data from a variety of sources. For example, in August 2023, US-based multinational company GE HealthCare introduced the CardioVisio, a clinical decision support tool centered on patients. This tool aids doctors in implementing evidence-based clinical decision-making drawn from up-to-date atrial fibrillation guidelines, and in visualizing longitudinal data from diverse sources relevant to disease progression. CardioVisio for atrial fibrillation can help cardiologists streamline the interpretation of clinical images, offering a view of the patient's cardiac history and overall healthcare trajectory, including past diagnoses, prescribed treatments, interventions, and co-existing conditions.

Which Segments in the Atrial Fibrillation Market Offer the Most Profit Potential?
The atrial fibrillation market covered in this report is segmented -

1) By Type: Surgical, Non-Surgical
2) By Technology: Radiofrequency, Laser, Cryotherapy, Other Technologies
3) By Treatment Type: Pharmacological Treatment, Non-pharmacological Treatment, Maze Surgery, Electric Cardioversion
4) By End User: Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers

Subsegments:
1) By Surgical: Catheter Ablation, Maze Procedure, Hybrid Ablation Procedures
2) By Non-Surgical: Antiarrhythmic Drugs, Anticoagulants, Cardioversion Procedures, Device Implants

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8007&type=smp

Which Firms Dominate the Atrial Fibrillation Market by Market Share and Revenue in 2025?
Major companies operating in the atrial fibrillation market are AtriCure Inc., Johnson & Johnson Private Limited, Abbott Laboratories, C.H. Boehringer Sohn AG & Co. KG, Biotronik Se & Co. Kg, Boston Scientific Corporation, Bristol-Myers Squibb Company, CardioFocus Inc., Sanofi S.A, Medtronic PLC, Biosense Webster Inc., MicroPort Scientific Corporation, Siemens AG, Acutus Medical Inc., AEGEA Medical Inc., Apama Medical Inc., Aria CV Inc., Armetheon Inc., BioSig Technologies Inc., Cardialen Inc., CardioRobotics Inc., CardioInsight Technologies Inc., Circa Scientific LLC, CorWave SA, EpiEP Inc., Farapulse Inc., Fibralign Corporation, Impulse Dynamics NV, JenaValve Technology Inc., Kardium Inc.

Which Regions Offer the Highest Growth Potential in the Atrial Fibrillation Market?
North America was the largest region in the atrial fibrillation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the atrial fibrillation market report forecast period. The regions covered in the atrial fibrillation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8007

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.